Leaflet LITHIUM CARBONICUM GSK 250mg tablets


Indicated for: bipolar disorder

Route of administration: oral

Substance: lithium carbonate (antipsychotic)

ATC: N05AN01 (Nervous system | Antipsychotics | Lithium)

Lithium carbonate is a medication used for the treatment of bipolar disorder, particularly for the prevention of manic and depressive episodes. It works by stabilizing neurotransmitter activity in the brain.

The medication is taken orally, usually two to three times a day, and the dose is adjusted based on blood lithium levels. Regular monitoring of serum lithium levels is essential to avoid toxicity.

Side effects may include tremor, nausea, diarrhea, or weight gain. In rare cases, toxicity may occur with symptoms such as confusion, seizures, or kidney failure.

Lithium carbonate is not recommended for patients with severe renal impairment, dehydration, or hypersensitivity to this medication. It is important to avoid excessive salt intake and maintain adequate hydration during treatment.

General data about LITHIUM CARBONICUM GSK 250mg

  • Substance: lithium carbonate
  • Date of last drug list: 01-08-2021
  • Commercial code: W54312001
  • Concentration: 250mg
  • Pharmaceutical form: tablets
  • Quantity: 60
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: GLAXO SMITHKLINE PHARMACEUTICALS S.A. - POLONIA
  • Holder: CN UNIFARM S.A. - ROMANIA
  • Number: 480/2020/01
  • Shelf life: 3 years